HP Inc. has announced that its Board of Directors has unanimously appointed Emma Walmsley as Chief Executive Officer, effective January 4, 2027. Emma most recently served as Chief Executive Officer of GSK and has been a member of Microsoft’s Board of Directors for seven years. She will succeed Bruce Broussard, who has served as Interim Chief Executive Officer since February 2026. Broussard will become Chair of the Board effective January 4, 2027, succeeding Chip Bergh. “HP has tremendous potential at an important inflection point in technology, and we need a leader who can build on our innovation heritage and strengths to boldly shape the company’s future. Emma is a proven CEO with a track record of leading organizations at scale and guiding them through significant change. She has the experience and skills to bring HP’s businesses, capabilities and people together to capture the opportunities ahead as AI moves to the edge, transforming how we work and live in a more connected world. I look forward to supporting her as she leads HP into its next phase of growth,” said Bruce Broussard, Interim Chief Executive Officer.
Emma is the former Chief Executive Officer of GSK, where she served from April 2017 through December 2025. During her nearly nine years as CEO, she led a significant transformation of the global biopharmaceutical company and delivered a step-change in its operating performance. She sharpened the company’s strategic focus on specialty medicines and vaccines, reinvigorated its R&D pipeline and strengthened the balance sheet following the successful separation of its consumer healthcare business, while enhancing GSK’s leadership bench and succession pipeline. Emma joined GSK in 2010 and became CEO of GSK Consumer Healthcare in 2015 before being appointed Group CEO. Earlier, she spent 17 years at L’Oréal building and leading major global consumer businesses.